In its latest bid to rein in the health care industry, the Federal Trade Commission filed a lawsuit accusing Surescripts of illegally monopolizing the market for e-prescribing, which refers to transmitting patient information and prescriptions among insurers, doctors, and pharmacies.

E-prescribing has becoming an important component of health care as public and private payers, as well as heath care providers, seek to streamline costs and speed important paperwork among key players. And Surescripts has been a dominant purveyor for more than a decade with a 95% market share, according to the lawsuit, which was filed on April 17 but disclosed by the agency on Wednesday.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • ED, I can guarantee you that Independent pharmacies weren’t part of that
    Loyalty Provision !!!!!!

Comments are closed.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy